Aurobindo Pharma (AUROBINDOP) was founded in 1986 by P.V.Ramaprasad Reddy, K.Nityananda Reddy and a small, highly committed set of professionals, the company became a public venture in 1992.
It commenced operations in 1988-89 with a single unit manufacturing semi synthetic penicillins (SSPs) at Pondicherry. Aurobindo Pharma is a fast-track integrated pharmaceutical company headquartered in Hyderabad, India, producing and marketing active pharmaceutical ingredients (bulk actives), intermediates and specialty generic formulations. AUROBINDOP ranks among the top five pharma companies in India and is a multi product, multi technology, transnational company.
The company`s products serve consumers in India and over 100 other countries including the markets of United States and Europe. Aurobindo Pharma is an R&D driven chemistry business house with a very broad product portfolio. The company has a presence in fast growing life style disease drugs, anti infective drugs, and key specialty therapeutics. Aurobindo Pharma is a known leader in the semi synthetic penicillin and cephalosporin. After creating a name for it in producing APIs and intermediates, the company sees major growth in its specialty generic formulations business.
In December 29, 2006, Agile Pharma B.V., the ultimate subsidiary of AUROBINDOP acquired 100% stake in the share capital of Pharmacin International B.V., The Netherlands AUROBINDOP sees its potential both in regulated and other global markets. In regulated markets, Aurobindo Pharma visualises profits aided by the thrust in building intellectual property. In the large growth segments of other global markets, it will succeed by virtue of its cost-efficient production. The company is based at Hyderabad, India.